Canal Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,352
| Closed | -$744K | – | 149 |
|
|
2022
Q4 | $744K | Buy |
26,352
+340
| +1% | +$9.6K | 0.18% | 89 |
|
|
2022
Q3 | $855K | Buy |
26,012
+3,226
| +14% | +$106K | 0.25% | 75 |
|
|
2022
Q2 | $718K | Buy |
22,786
+674
| +3% | +$21.2K | 0.21% | 78 |
|
|
2022
Q1 | $1.02M | Sell |
22,112
-4,540
| -17% | -$209K | 0.27% | 69 |
|
|
2021
Q4 | $1.63M | Buy |
26,652
+19,154
| +255% | +$1.17M | 0.39% | 62 |
|
|
2021
Q3 | $560K | Buy |
7,498
+410
| +6% | +$30.6K | 0.16% | 87 |
|
|
2021
Q2 | $656K | Buy |
7,088
+412
| +6% | +$38.1K | 0.19% | 84 |
|
|
2021
Q1 | $592K | Sell |
6,676
-3,537
| -35% | -$314K | 0.2% | 86 |
|
|
2020
Q4 | $952K | Buy |
10,213
+725
| +8% | +$67.6K | 0.36% | 66 |
|
|
2020
Q3 | $604K | Buy |
9,488
+1,902
| +25% | +$121K | 0.26% | 79 |
|
|
2020
Q2 | $396K | Hold |
7,586
| – | – | 0.19% | 86 |
|
|
2020
Q1 | $237K | Buy |
+7,586
| New | +$237K | 0.13% | 94 |
|